PCSK9 and diabetes mellitus: According to a WGRS derived using PCSK9, we noted that an LDL-C reduction of 1 mmol/L was associated with an increased risk of DM (OR 1.61, 95% CI: 1.04–2.49), and that an LDL-C reduction of 1 mg/dL was associated with an increased risk of DM (OR 1.01, 95% CI: 1.00–1.02).